ACTRIMS Forum 2021 - Scientific Sessions
ACTRIMS Forum 2021
The ACTRIMS Forum 2021 was held virtually on February 25-27, 2021. Its theme was "The Spectrum of Multiple Sclerosis". The sixth annual ACTRIMS Forum had over 1,700 attendees.
The ACTRIMS Forum is an annual translational science meeting highlighting novel and rigorous scientific discoveries made in MS that advance our understanding of research and clinical care of MS patients.
Course Details
For Distributors
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
| Quantity | Price per voucher |
|---|---|
| 1+ | $0.00 |
| Resources |
| Agenda and Program Book | ||
| MS Journal |
| KJ1/BA1. Kenneth P. Johnson Memorial Lecture & NMSS Barancik Award Talk |
| KJ1. Kenneth P. Johnson Memorial Lecture | ||
| BA1. NMSS Barancik Award Talk | ||
| KJ1/BA1 - Full Recording with Opening Remarks |
| S1. Session 1 - Emerging Concepts in MS |
| S1.1 Associations of Serum Neurofilament Light Chain with Clinical and Radiological Measures in a Large Real World MS Population | ||
| S1.2 Role of MCAM+ Regulatory T Cells in Multiple Sclerosis | ||
| S1.3 Low Sun Exposure is a Risk Factor for Pediatric-Onset Multiple Sclerosis | ||
| S1.4 Adult-Onset Genetic Leukodystrophies Misdiagnosed as Multiple Sclerosis in Clinical Practice | ||
| S1.5 Characteristics and Predictors of Disease Course in Children Initially Presenting with ADEM | ||
| S1.6 Single Cell and Spatial RNA Sequencing Identify Candidates that Drive Aging-Exacerbated Neurodegeneration in the Spinal Cord | ||
| Session 1 - Full Recording with LIVE Q&A |
| S2. Session 2 - The Spectrum of MS Across the Lifespan |
| S2.1 Pediatric Onset-Effects on Cognition and Long-Term Learning | ||
| S2.2 Aging and Rejuvenation of Oligodendrocytes | ||
| S2.3 Effects of Aging on MS | ||
| S2.4 Menopause and Hormonal Effects | ||
| Session 2 - Full Recording with LIVE Q&A |
| S3. Session 3 - LACTRIMS - The Spectrum of MS in the Hispanic and Latino Populations |
| S3.1 The Reality of MS Epidemiology in LATAM | ||
| S3.2 The Relationship Between Obesity and MS Metabolic-Immunological Interaction | ||
| S3.3 Spectrum of MS Demographics in LATAM Population | ||
| S3.4 MS and Intestinal Microbiota in LATAM Population | ||
| Session 3 - Full Recording with LIVE Q&A |
| CE1. Cutting Edge Developments |
| CE1.1 COVID-19 and MS-Registry Information | ||
| CE1.2 Vaccination Responses in Setting of Different Types of MS DMTs | ||
| CE1.4 Patterns of Disease-Modifying Treatment Use and Sociodemographic Characteristics in Multiple Sclerosis by Race and Ethnicity | ||
| CE1.5 Human Oligodendrocyte Lineage and Functional States Revealed by Single-Cell RNA Sequencing Analysis | ||
| CE1.6 Adenosine 2A Receptor Expression in Progressive MS is Associated with Astroglial Pan-activation and High Oxidative Toxicity | ||
| CE1.7 Quantification of Meningeal Enhancing Volume Reveals Relationships with Clinical Outcomes and Cortical Thinning on 7T MRI in MS | ||
| CE1 - Full Recording with LIVE Q&A |
| S4. Session 4 - The Spectrum of Inflammation and Environmental Impacts on Inflammation |
| S4.1 Inflammasomes and Pyroptosis in MS | ||
| S4.2 Mechanisms of Inflammation – Vitamin D Effects on Myeloid Cells | ||
| S4.3 Weight, Obesity and Adipokines | ||
| S4.4 Impact of Methionine Intake on Inflammation | ||
| Session 4 - Full Recording with LIVE Q&A |
| S5. Session 5 - The Spectrum of Other Non-MS Inflammatory CNS Diseases |
| S5.1 Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica | ||
| S5.2 NMO and Anti-MOG: Updates on Diagnosis and Treatment | ||
| S5.3 CNS Inflammatory Complications of Check-point Inhibitors | ||
| S5.4 Autoimmune Encephalitis | ||
| Session 5 - Full Recording with LIVE Q&A |
| S6. Session 6 - The Spectrum of Disease Severity: From Benign to Aggressive MS |
| S6.1 The Innate Immune System in Progressive MS | ||
| S6.2 Spectrum of Imaging Findings in Benign vs. Aggressive MS | ||
| S6.3 Cerebral/Cognitive-Predominant MS | ||
| S6.4 Benign MS and Aggressive MS – Nature or Nurture? | ||
| Session 6 - Full Recording with LIVE Q&A |
| Affiliate Partner Sessions |
| AP1. European Charcot Foundation Symposium: Silent Progression - Does it Exist? | ||
| AP2. IMSVISUAL Symposium | ||
| AP3. iWiMS Session: Meet iWiMS | ||
| AP4. NAIMS Symposium: Big Data and Machine Learning with MRI in Multiple Sclerosis |